Aura Investments Limited (IL:AURA)
TASE:AURA
Want to see IL:AURA full AI Analyst Report?
Top Page
Aura
(TASE:AURA)
Select Model
Select Model
Rating:54Neutral
Price Target:
1,905.00
▼(-14.30% Downside)
Action:Reiterated
Date:05/30/26
The score is primarily constrained by weak financial resilience—especially deeply negative operating/free cash flow and higher leverage—despite strong revenue growth and solid operating profitability. Technical indicators are bearish and reinforce near-term risk, while valuation is moderate and only slightly supportive.
Positive Factors
Top-line Momentum
Sustained high revenue growth across 2023–2025 demonstrates expanding commercial traction and market demand. That multi-year top-line momentum supports reinvestment in R&D and operations, improving the company’s ability to scale programs and fund longer-term development without immediate product sales.
Negative Factors
Negative Operating and Free Cash Flow
Persistent negative operating and free cash flow since 2023 means reported earnings are not converting to cash, increasing dependence on external financing. Over a multi-month horizon this raises funding and execution risk, as cash burn can force dilutive equity raises or higher-cost debt if operations don’t turn cash-positive.
Read all positive and negative factors
Positive Factors
Negative Factors
Top-line Momentum
Sustained high revenue growth across 2023–2025 demonstrates expanding commercial traction and market demand. That multi-year top-line momentum supports reinvestment in R&D and operations, improving the company’s ability to scale programs and fund longer-term development without immediate product sales.
Read all positive factors
Aura (AURA) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪5.12B
Dividend Yield0.66%
Average Volume (3M)582.98K
Price to Earnings (P/E)19.1
Beta (1Y)1.82
Revenue Growth31.85%
EPS Growth-25.26%
CountryIL
Employees141
SectorFinancial
Sector Strength70
IndustryReal Estate - Services
Share Statistics
EPS (TTM)0.93
Shares Outstanding285,637,330
10 Day Avg. Volume661,914
30 Day Avg. Volume582,982
Financial Highlights & Ratios
PEG Ratio-0.88
Price to Book (P/B)3.58
Price to Sales (P/S)3.03
P/FCF Ratio-6.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aura Business Overview & Revenue Model
Company Description
Established in 1992 and based in Tel Aviv, Israel, Aura Investments Ltd. is an Israeli real estate firm dedicated to the conceptualization and execution of property developments. Its operations primarily involve the construction of new residential...
How the Company Makes Money
As a clinical-stage biotechnology company, Aura Biosciences does not have publicly disclosed recurring product revenue from commercialized drugs. Its operations have historically been funded primarily through financing activities such as the issua...
Aura Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
55
Neutral
Cash Flow
24
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.03B | 1.90B | 1.52B | 1.04B | 849.01M | 893.89M |
| Gross Profit | 540.04M | 486.15M | 347.51M | 190.98M | 139.44M | 137.10M |
| EBITDA | 605.89M | 589.25M | 477.33M | 208.47M | 205.55M | 182.64M |
| Net Income | 267.49M | 280.75M | 360.14M | 117.69M | 140.54M | 113.53M |
Balance Sheet | ||||||
| Total Assets | 8.32B | 7.87B | 4.88B | 3.14B | 2.60B | 1.86B |
| Cash, Cash Equivalents and Short-Term Investments | 577.46M | 663.97M | 137.03M | 129.36M | 73.21M | 67.45M |
| Total Debt | 3.91B | 3.32B | 2.26B | 1.36B | 845.63M | 828.08M |
| Total Liabilities | 6.38B | 6.00B | 3.59B | 2.24B | 1.93B | 1.34B |
| Stockholders Equity | 1.67B | 1.61B | 1.27B | 882.03M | 652.64M | 520.38M |
Cash Flow | ||||||
| Free Cash Flow | -1.07B | -925.57M | -127.40M | -565.56M | 163.03M | 207.27M |
| Operating Cash Flow | -1.06B | -921.50M | -122.29M | -564.73M | 167.92M | 207.99M |
| Investing Cash Flow | 156.56M | 170.56M | -412.89M | -5.13M | -141.69M | -56.88M |
| Financing Cash Flow | 1.19B | 972.09M | 540.60M | 607.07M | -26.42M | -194.34M |
Aura Technical Analysis
Neutral
2223.00
Price Trends
1987.63
Negative
2111.41
Negative
2138.09
Negative
Market Momentum
-70.92
Negative
46.60
Neutral
60.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AURA, the sentiment is Neutral. The current price of 2223 is above the 20-day moving average (MA) of 1847.40, above the 50-day MA of 1987.63, and above the 200-day MA of 2138.09, indicating a neutral trend. The MACD of -70.92 indicates Negative momentum. The RSI at 46.60 is Neutral, neither overbought nor oversold. The STOCH value of 60.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:AURA.
Aura Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ₪9.89B | 15.68 | ― | 1.10% | -13.46% | 0.38% | |
64 Neutral | ₪8.01B | 8.23 | ― | ― | ― | ― | |
54 Neutral | ₪5.12B | 19.13 | ― | 0.66% | 31.85% | -25.26% | |
43 Neutral | ₪7.54B | 443.61 | ― | 2.42% | 15.70% | -67.34% |
* Financial Sector Average
IL:AURA
Aura
1,860.00
16.24
0.88%
IL:SMT
Summit
4,808.00
-26.46
-0.55%
IL:MVNE
Mivne
1,375.00
348.12
33.90%
IL:ALHE
Alony Hetz
3,467.00
654.30
23.26%
IL:AFPR
Afi Properties
19,760.00
900.00
4.77%
IL:BLSR
Blue Sq Real Es
37,560.00
8,054.34
27.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.